Literature DB >> 15719870

Left ventricular diastolic function parameters in hypertensives.

Adewole A Adebiyi1, Akinyemi Aje, Okechukwu S Ogah, Dike B Ojji, Olulola O Oladapo, Ayodele O Falase.   

Abstract

BACKGROUND: Hypertension is associated with left ventricular diastolic function abnormalities. There have been few studies evaluating left ventricular diastolic function in an African populace.
MATERIALS AND METHODS: Ninety-eight hypertensives (52 females, 46 males) and 99 normal controls (49 females, 50 males) were recruited for echocardiography. M-mode measurements and Doppler measurements of Mitral inflow and pulmonary venous flow were taken.
RESULTS: The hypertensives had significantly larger left ventricular wall thicknesses than the controls PWT: 0.93 (0.214) vs. 0.88 (0.130), p=0.039: septum: 0.93 (0.255) vs. 0.87 (0.131), p=0.039. The left ventricular mass indexed to the allometric power of height was larger in the hypertensives than in the controls. The Doppler parameters of peak A-wave velocity, E/A ratio, deceleration time, peak pulmonary venous S-wave, peak pulmonary venous D-wave, S/D ratio and peak pulmonary reverse flow velocity were significantly different between the hypertensives and the controls. The major determinant of left ventricular diastolic function parameters were age and the duration of hypertension. The level of the systolic blood pressure, left atrial size and ejection fraction are less important determinants.
CONCLUSION: Nigerian hypertensives have significantly different diastolic function indices when compared with normal controls.

Entities:  

Mesh:

Year:  2005        PMID: 15719870      PMCID: PMC2568572     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

Review 1.  Tissue Doppler imaging for the assessment of left ventricular systolic and diastolic functions.

Authors:  Karl Isaaz
Journal:  Curr Opin Cardiol       Date:  2002-09       Impact factor: 2.161

2.  Prevalence of isolated left ventricular diastolic dysfunction in hypertension as assessed by combined transmitral and pulmonary vein flow Doppler study.

Authors:  C Rusconi; T Sabatini; P Faggiano; G Ghizzoni; C Oneglia; U Simoncelli; A Gualeni; A Sorgato; A Marchetti
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

3.  Relation of left ventricular diastolic properties to systolic function in arterial hypertension.

Authors:  G de Simone; R Greco; G Mureddu; C Romano; R Guida; A Celentano; F Contaldo
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

4.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

5.  Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Authors:  K Wachtell; G Smith; E Gerdts; B Dahlöf; M S Nieminen; V Papademetriou; J N Bella; H Ibsen; J Rokkedal; R B Devereux
Journal:  Am J Cardiol       Date:  2000-02-15       Impact factor: 2.778

6.  Left ventricular diastolic function in essential hypertensive patients: influence of age and left ventricular geometry.

Authors:  Eduardo Cantoni Rosa; Valdir Ambrósio Moysés; Ivan Rivera; Ricardo da Cintra Sesso; Nárcia Kohlmann; Maria Tereza Zanella; Artur Beltrame Ribeiro; Osvaldo Kohlmann
Journal:  Arq Bras Cardiol       Date:  2002-05       Impact factor: 2.000

7.  Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.

Authors:  T Oki; N Fukuda; A Iuchi; T Tabata; M Sasaki; K Kawahara; T Ishimoto; T Tominaga; H Okushi; T Fujimoto; S Ito
Journal:  J Card Fail       Date:  1995-12       Impact factor: 5.712

8.  The relationship between diastolic dysfunction and level of blood pressure in Blacks.

Authors:  S O Ike; B J C Onwubere
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

9.  Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension.

Authors:  A R Snider; S S Gidding; A P Rocchini; A Rosenthal; M Dick; D C Crowley; J Peters
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

Review 10.  Diastolic dysfunction in hypertension.

Authors:  Michel Slama; Dinko Susic; Jasmina Varagic; Edward D Frohlich
Journal:  Curr Opin Cardiol       Date:  2002-07       Impact factor: 2.161

View more
  5 in total

1.  Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension.

Authors:  Viktor Persic; Alen Ruzic; Bojan Miletic; Sanja Balen; Zeljko Jovanovic; Aleksandar Vcev; Sanjin Racki; Bozidar Vujicic
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review.

Authors:  Okechukwu S Ogah; Ikechi Okpechi; Innocent I Chukwuonye; Joshua O Akinyemi; Basden Jc Onwubere; Ayodele O Falase; Simon Stewart; Karen Sliwa
Journal:  World J Cardiol       Date:  2012-12-26

3.  Left Ventricular Diastolic Function in Nigerian Patients with Essential Hypertension: A Retrospective Study to Compare Angiotensin Converting Enzyme Inhibitors, Calcium Channel Blockade or Their Combination.

Authors:  Olufemi E Ajayi; Anthony O Akintomide; Adegboyega Q Adigun; Adesuyi A L Ajayi
Journal:  Arch Drug Inf       Date:  2008-07

4.  Prevalence of asymptomatic left ventricular systolic dysfunction in hypertensive Nigerians: echocardiographic study of 832 subjects.

Authors:  O S Ogah; R O Akinyemi; G D Adegbite; O I Udofia; S B Udoh; J O Adesina; O S Ojo; A A Alabi; T Majekodunmi; J K Osinfade; R F Ogundipe; A O Falase
Journal:  Cardiovasc J Afr       Date:  2011 Nov-Dec       Impact factor: 1.167

5.  "Echocardiography in Nigeria: use, problems, reproducibility and potentials".

Authors:  Okechukwu S Ogah; Ademola T Adebanjo; Adedeji S Otukoya; Tarwanger J Jagusa
Journal:  Cardiovasc Ultrasound       Date:  2006-03-21       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.